跳至主要内容
临床试验/NCT07147764
NCT07147764招募中不适用

Comparison of the Effect of Pain Neuroscience Education Combined With Physiotherapy, and Physiotherapy Alone in Temporomandibular Disorders

Ainaz Shahedi2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年9月14日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
36
试验地点
2
主要终点
The Craniofacial Pain and Disability Inventory (CF-PDI)

研究概览

简要总结

This research study aims to evaluate the effectiveness of Pain Neuroscience Education (PNE) when it is added to a physiotherapy program for people experiencing chronic temporomandibular disorders (TMD). To see whether adding PNE to physiotherapy program would provides additional benefits in reducing pain intensity, improving psychological well-being, and enhancing functional outcomes. The findings are expected to provide new insights into more comprehensive and patient-centered treatment strategies for managing chronic TMD.

Participants will be randomly assigned to one of two groups:

Control Group: Physiotherapy only

PNE Group: Physiotherapy plus Pain Neuroscience Education

Both groups will receive their respective treatments for a set period of time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with pain-related TMDs according to DC/TMD guidelines
  • Chronic TMD pain, defined as experiencing pain for at least six months and feeling the pain during the last 30 days
  • Age between 18-65 years

排除标准

  • Illiterate patients
  • Severe depression (medical diagnoses)
  • Previous diagnosis of uncontrolled psychiatric disorder neurodegenerative diseases
  • Clinical history of tumors in the craniofacial region
  • Patients in the post dental surgery period
  • Patients who were submitted to previous physical therapy in the past year or to any health/pain education strategy
  • Pregnant women
  • Infections, whiplash-associated disorders and with chronic degenerative inflammatory or neurologic disorders

结局指标

主要结局

The Craniofacial Pain and Disability Inventory (CF-PDI)

时间窗: Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up

It consists of 21 items, with a score ranging from 0 to 63 points. Each question is scored on a 4-point ordinal scale, ranging from 0 to 3. A higher score reflects higher disability levels.

The Craniofacial Pain and Disability Inventory (CF-PDI)

时间窗: Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up

It consists of 21 items, with a score ranging from 0 to 63 points. Each question is scored on a 4-point ordinal scale, ranging from 0 to 3. A higher score reflects higher disability levels.

次要结局

  • Numeric Pain Rating Scale (NPRS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Pain Self-Efficacy Questionnaire (PSEQ)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Pain Catastrophizing Scale (PCS)(Baseline,1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Hospital Anxiety and Depression Scale (HADS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • The Tampa Scale for Kinesiophobia specific to Temporomandibular Disorders (TSK-TMD)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Revised Neurophysiology of Pain Questionnaire (rNPQ)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • The Exercise Adherence Rating Scale (EARS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Fear Avoidance Components Scale (FACS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Numeric Pain Rating Scale (NPRS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Pain Self-Efficacy Questionnaire (PSEQ)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Pain Catastrophizing Scale (PCS)(Baseline,1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Hospital Anxiety and Depression Scale (HADS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • The Tampa Scale for Kinesiophobia specific to Temporomandibular Disorders (TSK-TMD)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Revised Neurophysiology of Pain Questionnaire (rNPQ)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • The Exercise Adherence Rating Scale (EARS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)
  • Fear Avoidance Components Scale (FACS)(Baseline, 1 month after start of treatment, Immediate post-treatment, 3 month follow up)

研究者

发起方
Ainaz Shahedi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ainaz Shahedi

MSc Candidate in Physiotherapy, Istanbul Medipol University

Istanbul Medipol University Hospital

研究点 (2)

Loading locations...

相似试验